Learning archive

STAT News · Research

Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?

STAT News · Research

Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?

Urologic oncologists who treat prostate cancer are split over the benefits of focal therapy compared to traditional surgery or radiation.

STAT News · Article

Opinion: A cure for HIV would be a triumph. But it shouldn’t harm survivors

Santa Monica Daily Press · Research

Red Cross Grant Expands Malibu Wildfire Recovery Effort

Sleep & Rest · Article

Exhausted after 8 hours of sleep? A neurologist reveals what time you should actually go to bed - HELLO! Magazine

Immunotherapy Updates · Research

Natalie Harp's cancer survival story: What we know - Snopes

Mayo Clinic · Video

Tiny Patients. BIG Teamwork. A CRNA’s Day in Pediatric Radiology at Mayo Clinic

Immunotherapy Updates · Research

Personalized Cancer Vaccines Just Got One Step Closer to Reality - Yahoo Health

Oncology Patient Care · Article

Nurses: The Lifeline for Dietitian Referrals in Cancer Care - Oncology Nursing News

Sleep & Rest · Article

Why a Cooler Bedroom Temperature Helps You Sleep Better - University of Utah Health

Cancer Research News · Research

Cancer breakthrough as personalised mRNA vaccine stops melanoma returning - Gavi, the Vaccine Alliance

Oncology Brothers · Podcast

EXCALIBER-RRMM - Iberdomide/Dara/Dex FDA Approval for R/R Multiple Myeloma: Dr. Sagar Lonial

Welcome to the Oncology Brothers podcast! In this episode, we were joined by Dr. Sagar Lonial, a myeloma specialist from the Emory University, to discuss the recent FDA approval of iberdomide, a novel cereblon modulator (CELMoDs), in combination with daratumumab and dexamethasone for the treatment of relapsed and refractory multiple myeloma. Join us as we dive into: The significance of the EXCALIB

Cancer Health Science · Research

Customized Melanoma Vaccine Lowers Relapse Risk in Late-Stage Trial

Personalized mRNA shot plus checkpoint inhibitor continues to show promise in the first Phase III read-out for this type of cancer vaccine.

Immunotherapy Updates · Article

Why the key to treating cancer may be in your gut, with Thomas Gajewski - University of Chicago News

ScienceDaily Nutrition · Article

Knee osteoarthritis isn’t inevitable — here’s what you can do

ScienceDaily Nutrition · Article

Knee osteoarthritis isn’t inevitable — here’s what you can do

Knee osteoarthritis can seriously affect mobility and quality of life, but its progression isn’t completely out of your control. Exercise, stronger leg muscles, a healthier diet, and even modest weight loss can dramatically reduce stress on the knees and help keep pain in check.

Immunotherapy Updates · Research

Noubar Afeyan: A Historic Phase 3 Win for mRNA Cancer Therapy in Melanoma - Oncodaily

NY Times Health · Research

What Is Treatment-Resistant Depression?

If multiple antidepressants haven’t helped, there are other avenues to explore.

NY Times Health · Article

What Is Treatment-Resistant Depression?

Immunotherapy Updates · Research

How Much of a Cancer Drug Is Too Much? Patients, Researchers Challenge FDA-Approved Dosages - KFF Health News

ASCO Daily News · Podcast

How Do We Translate ASCO26 Research Into Practice in Latin America?

In part two of our miniseries on the global translation gap in oncology, host Dr. Monty Pal and Dr. Regina Barragán-Carrillo explore how ASCO26 Plenary breakthroughs can be adapted to clinical practice in Latin America. Together, they address real-world implementation challenges including delayed diagnoses, finite resource allocation, and access to precision diagnostics. LINK TO FULL TRANSCRIPT

STAT News · Research

Can reclassifying muscle dysmorphia unlock better care for boys and men?

Males make up about a third of the population struggling with eating disorders in the United States. While these conditions often start during the teen years, by some estimates, as…

STAT News · Article

Reduce protein to increase longevity? Nutrition experts say that’s a bad idea

STAT News · Research

Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study

“Regulatory flexibility can be exercised in rare disease without sacrificing rigor,” writes Mindy Leffler, whose son has Duchenne muscular dystrophy.